Clinical Trials Browser

Phase 3 × OTHER_GOV × Breast Neoplasms × Clear all

NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Phase 3 Recruiting

Breast Neoplasms

NCT01785420 2025-04-09

Pre Operative Trastuzumab in Operable Breast Cancer

Phase 3 Recruiting

Breast Neoplasms

NCT03423199 2024-03-22

PATHWAY

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT05474690 2024-02-26

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Phase 3 Withdrawn

Pathologic Complete Response, Breast Neoplasms

NCT02995772 2019-06-19

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Phase 3 Completed

Breast Neoplasms

NCT00193726 2018-09-20

Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer

Phase 3 Terminated

Breast Neoplasms

NCT02865304 2016-08-12

The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients

Phase 3 Unknown

Breast Neoplasms

NCT02525159 2015-08-17

EDIMI216OHE1

Phase 3 Completed

Breast Neoplasms

NCT01501669 2012-07-18

PROCEED

Phase 3 Unknown

Breast Neoplasms

NCT01452672 2011-10-17

Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00896155 2011-08-30

CONSET

Phase 3 Unknown

Breast Neoplasms, Pulmonary Fibrosis

NCT00352378 2011-06-27

Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT01116713 2010-05-05

dxt2010brca

Phase 3 Completed

Breast Neoplasms, Pain, Postoperative, Postoperative Nausea and Vomiting